Zacks Bull and Bear of the Day Highlights: InterDigital Communications, MannKind, Natural Resource Partners and NovaMed.CHICAGO -- Zacks Equity Research highlights InterDigital interdigital between two digits. interdigital cysts see interdigital pyoderma, pododermatitis. interdigital dermatitis 1. the early lesion in the development of infectious footrot in sheep; called also sheep scald. Communications (Nasdaq:IDCC IDCC Integrated Dual-use Commercial Companies ) as the Bull of the Day and MannKind Corporation MannKind Corporation (Nasdaq:MNKD ) is a biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. (Nasdaq:MNKD) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Natural Resource Partners (NYSE NYSE See: New York Stock Exchange :NRP (Network Resource Planning) The planning, scheduling and control of a computer network. It includes documentation writing and network diagramming, analyses of traffic and congestion, analyses of application behavior and demand, procedures for failsafe and disaster ) and NovaMed, Inc. (Nasdaq:NOVA). Full analysis of all four stocks is available at http://at.zacks.com/?id=2676. Here is a synopsis of all four stocks: Bull of the Day: Our Bull of the Day recommendation is for InterDigital Communications (Nasdaq:IDCC), a leading wireless technology and licensing company, announced third quarter (ended September) results with net income increasing more than three fold year-over-year. This was primarily driven by increased recurring royalties from existing licenses and royalty received from Nokia Corp as previous dispute settlement. The company has a solid licensing program which is further augmented by a substantial $134 million arbitration award An arbitration award (or arbitral award) is a determination on the merits by an arbitration tribunal in an arbitration, and is analogous to a judgment in a court of law. given by International Chamber of Commerce, related to a patent dispute with Samsung Electronics Samsung Electronics (SEC, Hangul:삼성전자; KSE: 005930, KSE: 005935, LSE: SMSN, LSE: SMSD) is a South Korean multinational corporation and the world's largest and leading electronics and information technology company. . Moreover, IDCC has a strong pipe-line consisting of a dual-mode 2G/3G HSDPA/HSUPA modem offering. The balance sheet also remains healthy with sequential positive free-cash flow. We continue to rate the stock a Buy based on cash generation, share buy-back initiatives and 3G wireless opportunities. Bear of the Day: Our Bear of the Day recommendation is for MannKind Corporation (Nasdaq:MNKD). MannKind is a biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic products for diabetes, cancer and inflammatory and autoimmune diseases Autoimmune diseases A group of diseases, like rheumatoid arthritis and systemic lupus erythematosus, in which immune cells turn on the body, attacking various tissues and organs. Mentioned in: Complement Deficiencies, Premature Menopause . Its lead product, the Technosphere Insulin System, for the treatment of diabetes, is in phase III Noun 1. phase III - a large clinical trial of a treatment or drug that in phase I and phase II has been shown to be efficacious with tolerable side effects; after successful conclusion of these clinical trials it will receive formal approval from the FDA trials in the U.S. We believe Technosphere has certain intriguing beneficial characteristics that could make the product a success. However, competition is fierce in this field, commercialization is still at least three years away and the company is burning cash at too high a rate. We rate the stock a Sell with a $14.50 price target. Analyst Blog: Natural Resource Partners (NYSE:NRP) reported surprisingly positive third quarter results this morning. The company was expected to see lower pricing due to the recent price decline of Central Appalachian coal. This was not the case, however, as NRP's per-ton royalties increased by 10.6% in the region. Management remarked that its quality, diverse base of properties led to the favorable result. EPU EPU Energy Processing Unit EPU Economic Planning Unit (Malaysia) EPU E Pluribus Unum EPU European Payments Union (organization formed after WWII) EPU Emergency Power Unit for the quarter was $0.85, compared to our estimate of $0.75. We have adjusted our full-year 06 earnings estimate accordingly, to $3.44 per unit. Our current six-month target price for NRP units remains unchanged, at $57, and we reiterate our Buy rating. NovaMed, Inc. (Nasdaq:NOVA) is an emerging healthcare services company engaged in the operation of ambulatory surgery centers ambulatory surgery center A free-standing center that performs various types of surgery (ASCs) and the provision of optical products and services to eye-care professionals. The company reported net income of $1.44M, or EPS (Encapsulated PostScript) A PostScript file format used to transfer a graphic image between applications and platforms. EPS files contain PostScript code as well as an optional preview image in TIFF, WMF, PICT or EPSI, the latter being an ASCII-only format. of $0.06 (in line with consensus), down 10% y/y compared with $1.60M, or EPS of $0.07, in 3Q05. Consolidated revenue for 3Q06 was $27.7M, up 33% y/y from $20.9M in 3Q05. Despite current HOPD related reimbursement risk, we regard NOVA as attractive at current levels given its robust pipeline and niche market A niche market also known as a target market is a focused, targetable portion (subset) of a market sector. By definition, then, a business that focuses on a niche market is addressing a need for a product or service that is not being addressed by mainstream providers. focus. We retain our Buy recommendation. Get the full analysis of all four stocks by going to http://at.zacks.com/?id=2649. About the Bull and Bear of the Day Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months. About the Analyst Blog Updated throughout every trading day, the Analyst Blog provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets. About Zacks Equity Research Zacks Equity Research provides the best of quantitative and qualitative analysis Qualitative Analysis Securities analysis that uses subjective judgment based on nonquantifiable information, such as management expertise, industry cycles, strength of research and development, and labor relations. to help investors know what stocks to buy and which to sell for the long-term. Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons. Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=2677. About Zacks Zacks.com is a property of Zacks Investment Research Zacks Investment Research A firm that compiles earnings estimates and brokerage firm investment recommendations for thousands of publicly traded firms. , Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros by going to http://at.zacks.com/?id=2650. Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. (a)The Zacks Performance Rank performance is the total return of equal weighted simulated portfolios consisting of those stocks with the indicated Zacks Rank net of fees. Results reflect the reinvestment of dividends and other earnings. Simulated results do not represent actual trading and may not reflect the impact that economic and market factors might have had on decision-making if an adviser were actually managing a client's money. (b)The S&P 500 Index ("S&P 500") is a well-known, unmanaged index of the prices of 500 large-company common stocks selected by Standard & Poor's. The S&P 500 includes the reinvestment of all dividends, no transaction costs Transaction Costs Costs incurred when buying or selling securities. These include brokers' commissions and spreads (the difference between the price the dealer paid for a security and the price they can sell it). , and represents the gross returns before management fees. Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion